Skip to main content
. 2021 Sep 3;2(9):100387. doi: 10.1016/j.xcrm.2021.100387

Figure 3.

Figure 3

Comparative exposures with oral versus injectable semaglutide

Data are mean relative exposures with 90% ranges obtained using the individual exposure estimates from the final PK model for subjects in PIONEER 1, 2, and 8 populations. For each individual, s.c. exposure estimates were predicted based on a dose and demographic factors using a reduced population PK model developed based on s.c. semaglutide data.16